Sanofi Digitalizes Disease Management Via Alibaba In China
Executive Summary
Sanofi has ventured deep into the digital health waters in China with an ambitious disease management plan covering 400 community clinics in 15 cities, in just a matter of months. To begin with, it is relying on partner Alibaba and its mobile health platform to progress plans.
You may also be interested in...
Pharma-BAT Digital Health Tango In China: Will It Pay Off?
China's internet giants Baidu, Alibaba and Tencent, collectively called BAT, are increasingly tapping into digital health to benefit from recent policy changes, and 2017 saw pharma companies eagerly jump onboard to share the potential gains.
GSK Bets On Online-To-Offline Push To Expand Reach In China
GSK’s alliance with AliHealth underscores its belief that the China market has significant room for growth if combined with the right technologies.
China Expands Grassroots Clinic Prescribing As Cardiovascular Epidemic Looms
In fresh move to reduce reliance on large hospitals to combat the challenge of chronic diseases, China is to allow community clinics to dispense the same drugs as larger hospitals, just as a new Harvard report projects an epidemic of heart disease and stroke in the country.